HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 48186,
"recordsTotal": 48186,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=status&start=46800",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=status&start=46200",
"results": [
{
"registry_id": "NCT06935474",
"publication_url": "https://clinicaltrials.gov/study/NCT06935474",
"title": "Multi-center, Phase 1/2 Study of an Autologous Anti-CD20/BCMA CAR T Cell Therapy (C-CAR168) for the Treatment of Autoimmune Disease Refractory to Standard Therapy",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbelZeta, Inc.",
"sponsor_slug": "abelzeta-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07437950",
"publication_url": "https://clinicaltrials.gov/study/NCT07437950",
"title": "A Randomized Phase II Trial of ASTX727 With Standard Duration Versus Shorter Duration of Venetoclax in Genomically Heterogenous AML Among Adults Aged 60 or Older and Less Fit for Intensive Therapy: A MyeloMATCH Substudy",
"has_exemption": false,
"start_date": "2026-10-14",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769854",
"publication_url": "https://clinicaltrials.gov/study/NCT06769854",
"title": "Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chi Dang Hornik",
"sponsor_slug": "chi-dang-hornik",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03258567",
"publication_url": "https://clinicaltrials.gov/study/NCT03258567",
"title": "Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2018-04-26",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548061",
"publication_url": "https://clinicaltrials.gov/study/NCT06548061",
"title": "Single Center Observational Study Using Spinal Laser Interstitial Thermal Therapy (sLITT) in the Treatment of Spine Metastases and Tumors",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06978088",
"publication_url": "https://clinicaltrials.gov/study/NCT06978088",
"title": "A Multicenter Parallel 2 Cohort Phase 2 Study of LP-168 and Obinutuzumab for Previously Treated, and T474 Gatekeeper Mutant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Zulfa Omer",
"sponsor_slug": "zulfa-omer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129993",
"publication_url": "https://clinicaltrials.gov/study/NCT07129993",
"title": "A Randomized, Open-Label, Phase 2/3 Study of Datopotamab Deruxtecan (Dato-DXd) Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Who Progressed During or After Enfortumab Vedotin (EV) Plus Pembrolizumab Combination Treatment TROPION-Urothelial03 (TU03)",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06816927",
"publication_url": "https://clinicaltrials.gov/study/NCT06816927",
"title": "A Multi-Center, Randomized, Phase 2 Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab (GIANT)",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06944145",
"publication_url": "https://clinicaltrials.gov/study/NCT06944145",
"title": "A Phase 2b Randomized, Single-Center, Double Blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha Reductase Inhibitor + Raloxifene) Compared With Monotherapy (5-alpha Reductase Inhibitor + Placebo) in Adult Patients With Benign Prostatic Hyperplasia (BPH)",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899764",
"publication_url": "https://clinicaltrials.gov/study/NCT05899764",
"title": "Epileptic Hippocampus in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07099638",
"publication_url": "https://clinicaltrials.gov/study/NCT07099638",
"title": "Randomized Factorial Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412120",
"publication_url": "https://clinicaltrials.gov/study/NCT06412120",
"title": "Single-Arm, Prospective, Multicenter Study Evaluating Safety, Tolerability, and Metabolism of Niraparib as Maintenance Following Front-Line Treatment for Ovarian Cancer in Women of African Ancestry",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07356284",
"publication_url": "https://clinicaltrials.gov/study/NCT07356284",
"title": "Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ProMedica Health System",
"sponsor_slug": "promedica-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07361484",
"publication_url": "https://clinicaltrials.gov/study/NCT07361484",
"title": "A Global, Multicenter, Randomized, Double-blinded, Phase 3 Study of Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer With EGFR, ALK, ROS, and RET Wild Type After Progressing on Prior Immunotherapy (Anti-PD-1/L1 Antibody) and Platinum-based Chemotherapy (DUBLIN-4)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "BeyondSpring Pharmaceuticals Inc.",
"sponsor_slug": "beyondspring-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07466498",
"publication_url": "https://clinicaltrials.gov/study/NCT07466498",
"title": "Estrogen for Quality-of-Life and Immune Modulation in Prostate Cancer (EQUIP)",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06448286",
"publication_url": "https://clinicaltrials.gov/study/NCT06448286",
"title": "PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07229339",
"publication_url": "https://clinicaltrials.gov/study/NCT07229339",
"title": "Phase 2 Trial of Zipalertinib in Patients With Resectable Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion or Uncommon/Compound Mutations",
"has_exemption": false,
"start_date": "2027-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430332",
"publication_url": "https://clinicaltrials.gov/study/NCT07430332",
"title": "Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function",
"has_exemption": false,
"start_date": "2027-09-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011758",
"publication_url": "https://clinicaltrials.gov/study/NCT07011758",
"title": "Dynamic Treatment Regimes for Personalized Opioid Use Disorder Care",
"has_exemption": false,
"start_date": "2028-07-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06900595",
"publication_url": "https://clinicaltrials.gov/study/NCT06900595",
"title": "A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer",
"has_exemption": false,
"start_date": "2026-02-22",
"completion_date": "2029-06-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04924075",
"publication_url": "https://clinicaltrials.gov/study/NCT04924075",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2029-06-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286214",
"publication_url": "https://clinicaltrials.gov/study/NCT07286214",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Each of Two Dose Levels of Sarilumab in Adults With Early Polymyalgia Rheumatica",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2029-06-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632457",
"publication_url": "https://clinicaltrials.gov/study/NCT06632457",
"title": "A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis",
"has_exemption": false,
"start_date": "2024-11-07",
"completion_date": "2029-06-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868290",
"publication_url": "https://clinicaltrials.gov/study/NCT06868290",
"title": "A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Active Granulomatosis With Polyangiitis (GPA) or Microscopic Polyangiitis (MPA)",
"has_exemption": false,
"start_date": "2025-03-13",
"completion_date": "2029-06-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218510",
"publication_url": "https://clinicaltrials.gov/study/NCT07218510",
"title": "A Phase 2 Study of Venetoclax + Obinutuzumab Followed by Epcoritamab in Previously Untreated Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (LonGEVity)",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2029-06-08",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07084584",
"publication_url": "https://clinicaltrials.gov/study/NCT07084584",
"title": "A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-06-10",
"completion_date": "2029-06-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Galecto Biotech AB",
"sponsor_slug": "galecto-biotech-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222761",
"publication_url": "https://clinicaltrials.gov/study/NCT07222761",
"title": "An Open-Label, Randomized Phase 3 Study of Linvoseltamab Monotherapy and Linvoseltamab Plus Carfilzomib Versus Standard of Care Combination Regimens in Patients With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2029-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06914128",
"publication_url": "https://clinicaltrials.gov/study/NCT06914128",
"title": "A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of BAY 3713372, a Novel 2nd Generation PRMT5 Inhibitor, in Participants With MTAP-deleted Solid Tumors.",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2029-06-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04368702",
"publication_url": "https://clinicaltrials.gov/study/NCT04368702",
"title": "Clinical Onboard Utilization of Image Guided Radiation Therapy With Magnetic Resonance (CONFIRM): A Master Protocol",
"has_exemption": false,
"start_date": "2021-05-01",
"completion_date": "2029-06-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276399",
"publication_url": "https://clinicaltrials.gov/study/NCT07276399",
"title": "A Phase 3, Randomized, Open-Label, Multicenter Study of Amivantamab in Addition to Carboplatin and Pembrolizumab, Compared to Standard of Care Platinum and Pembrolizumab and 5-FU, in Participants With Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-06-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03950232",
"publication_url": "https://clinicaltrials.gov/study/NCT03950232",
"title": "An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2019-09-05",
"completion_date": "2029-06-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013747",
"publication_url": "https://clinicaltrials.gov/study/NCT07013747",
"title": "A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Participants With Mild Acne",
"has_exemption": false,
"start_date": "2025-07-03",
"completion_date": "2029-06-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042581",
"publication_url": "https://clinicaltrials.gov/study/NCT07042581",
"title": "Evaluation of Revaree Plus in Women With Breast Cancer",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2029-06-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06477419",
"publication_url": "https://clinicaltrials.gov/study/NCT06477419",
"title": "Phase 2 Study of Sacituzumab Govitecan-hziy in Patients With Previously Treated Mesothelioma",
"has_exemption": false,
"start_date": "2024-06-21",
"completion_date": "2029-06-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852222",
"publication_url": "https://clinicaltrials.gov/study/NCT06852222",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A Rearrangements or NPM1 Mutations Who Are Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2029-06-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937229",
"publication_url": "https://clinicaltrials.gov/study/NCT06937229",
"title": "A Phase 3, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-3)",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2029-06-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228273",
"publication_url": "https://clinicaltrials.gov/study/NCT07228273",
"title": "A Phase II Randomized Clinical Trial of Venetoclax Combined With FLAG IDA Induction and Consolidation Compared to Standard of Care for Newly Diagnosed Patients With Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-06-24",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06033833",
"publication_url": "https://clinicaltrials.gov/study/NCT06033833",
"title": "A Long-term Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study",
"has_exemption": false,
"start_date": "2023-09-05",
"completion_date": "2029-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06044337",
"publication_url": "https://clinicaltrials.gov/study/NCT06044337",
"title": "A Multicenter, Open-Label, Single-Arm, Phase 3, Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2029-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339423",
"publication_url": "https://clinicaltrials.gov/study/NCT07339423",
"title": "Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)",
"has_exemption": false,
"start_date": "2026-02-24",
"completion_date": "2029-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05847569",
"publication_url": "https://clinicaltrials.gov/study/NCT05847569",
"title": "Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Class Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2029-06-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07207811",
"publication_url": "https://clinicaltrials.gov/study/NCT07207811",
"title": "CLEOPATTRA: Effects of NNC6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)",
"has_exemption": false,
"start_date": "2025-10-02",
"completion_date": "2029-06-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06573970",
"publication_url": "https://clinicaltrials.gov/study/NCT06573970",
"title": "Atomoxetine Effect on Attention, Executive Function, and Quality of Life in Veterans With Posttraumatic Stress Disorder",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-06-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03887455",
"publication_url": "https://clinicaltrials.gov/study/NCT03887455",
"title": "A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2019-03-27",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eisai Inc.",
"sponsor_slug": "eisai-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04120493",
"publication_url": "https://clinicaltrials.gov/study/NCT04120493",
"title": "A Phase 1/2, Randomized, Double-Blind, Sham Control and Open-Label Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gene (HTT) Lowering Therapy (AMT-130) in Early Manifest Huntington's Disease",
"has_exemption": false,
"start_date": "2019-09-06",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "UniQure Biopharma B.V.",
"sponsor_slug": "uniqure-biopharma-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04296903",
"publication_url": "https://clinicaltrials.gov/study/NCT04296903",
"title": "Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)",
"has_exemption": false,
"start_date": "2020-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apifix",
"sponsor_slug": "apifix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04404660",
"publication_url": "https://clinicaltrials.gov/study/NCT04404660",
"title": "An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia",
"has_exemption": false,
"start_date": "2020-06-03",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Autolus Limited",
"sponsor_slug": "autolus-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04298723",
"publication_url": "https://clinicaltrials.gov/study/NCT04298723",
"title": "Randomized Comparison of Interventional Closure of the Left Atrial Appendage Using a LAA Closure Device Versus Oral Anticoagulation Therapy in Patients With Non-valvular Atrial Fibrillation and Status Post Intracranial Bleeding.",
"has_exemption": false,
"start_date": "2020-06-16",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jena University Hospital",
"sponsor_slug": "jena-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04293562",
"publication_url": "https://clinicaltrials.gov/study/NCT04293562",
"title": "A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations",
"has_exemption": false,
"start_date": "2020-07-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04671667",
"publication_url": "https://clinicaltrials.gov/study/NCT04671667",
"title": "A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features",
"has_exemption": false,
"start_date": "2021-04-27",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04889872",
"publication_url": "https://clinicaltrials.gov/study/NCT04889872",
"title": "The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement",
"has_exemption": false,
"start_date": "2021-10-12",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05268614",
"publication_url": "https://clinicaltrials.gov/study/NCT05268614",
"title": "Risk Adapted De-Intensification of Radio-Chemotherapy for Favorable Prognosis Oropharyngeal Squamous Cell Carcinoma Based on HPV Subtype and Plasma Circulating Free HPV DNA Level and Clearance Rate",
"has_exemption": false,
"start_date": "2022-05-16",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05650658",
"publication_url": "https://clinicaltrials.gov/study/NCT05650658",
"title": "Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing With a Left Ventricular Epicardial Lead in Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF)≤50% and With Either a Wide QRS Complex (>130 ms) or With/Anticipated >40% Pacing Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2023-09-13",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05609630",
"publication_url": "https://clinicaltrials.gov/study/NCT05609630",
"title": "A Multicenter, Randomized Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Upadacitinib With a Tocilizumab Reference Arm in Subjects From 1 Year to Less Than 18 Years Old With Active Systemic Juvenile Idiopathic Arthritis",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05863195",
"publication_url": "https://clinicaltrials.gov/study/NCT05863195",
"title": "A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial",
"has_exemption": false,
"start_date": "2023-10-19",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06245889",
"publication_url": "https://clinicaltrials.gov/study/NCT06245889",
"title": "A Pilot Study of Neoadjuvant Response-Adapted Chemotherapy With Pembrolizumab in Patients With Stage 2 and 3 Triple Negative Breast Cancer to Determine Early PET and Biomarker Dynamics",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408181",
"publication_url": "https://clinicaltrials.gov/study/NCT06408181",
"title": "APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia",
"has_exemption": false,
"start_date": "2024-06-12",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06513182",
"publication_url": "https://clinicaltrials.gov/study/NCT06513182",
"title": "Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty? A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-06-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05711667",
"publication_url": "https://clinicaltrials.gov/study/NCT05711667",
"title": "Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315738",
"publication_url": "https://clinicaltrials.gov/study/NCT06315738",
"title": "Randomized, Controlled, Phase 1-2 Open Label Study of ST266 IV Administration to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Noveome Biotherapeutics, formerly Stemnion",
"sponsor_slug": "noveome-biotherapeutics-formerly-stemnion",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06486441",
"publication_url": "https://clinicaltrials.gov/study/NCT06486441",
"title": "A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470243",
"publication_url": "https://clinicaltrials.gov/study/NCT06470243",
"title": "A Phase III Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC), Stratified by Aggressive Variant Signature",
"has_exemption": false,
"start_date": "2024-11-27",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06641414",
"publication_url": "https://clinicaltrials.gov/study/NCT06641414",
"title": "A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).",
"has_exemption": false,
"start_date": "2025-01-22",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascentage Pharma Group Inc.",
"sponsor_slug": "ascentage-pharma-group-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721819",
"publication_url": "https://clinicaltrials.gov/study/NCT06721819",
"title": "The SCOPE Trial: Sleep, Cognition, and Pain Bundle Vs. ERAS-cardiac for Postoperative Delirium",
"has_exemption": false,
"start_date": "2025-02-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06582875",
"publication_url": "https://clinicaltrials.gov/study/NCT06582875",
"title": "Advancing ADPKD Treatment With GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592586",
"publication_url": "https://clinicaltrials.gov/study/NCT06592586",
"title": "A Follow-up Trial to Assess the Persistence of the Immune Response to the Group B Streptococcus Vaccine (GBS-NN/NN2) After a Primary Vaccination of Healthy Pregnant Women, and to Assess Safety, Reactogenicity, and Immunogenicity of the GBS-NN/NN2 Vaccine When Administered During Follow-Up as a 1 Booster Dose During a New Pregnancy",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Minervax ApS",
"sponsor_slug": "minervax-aps",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06291064",
"publication_url": "https://clinicaltrials.gov/study/NCT06291064",
"title": "TreAtment Response and Omic-Markers in Triple-Negative Breast CAncer Patients Receiving Standard of Care Chemotherapy (TARMAC)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161974",
"publication_url": "https://clinicaltrials.gov/study/NCT06161974",
"title": "Phase 2 Study of Olutasidenib with Temozolomide As Maintenance Therapy in Pediatric and Young Adult Patients Newly Diagnosed with High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor IDH1 Mutations",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rigel Pharmaceuticals",
"sponsor_slug": "rigel-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06231563",
"publication_url": "https://clinicaltrials.gov/study/NCT06231563",
"title": "Examining Ketamine Effects on Depression, Neuroplasticity, and Inflammation in Veterans With Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06609369",
"publication_url": "https://clinicaltrials.gov/study/NCT06609369",
"title": "Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse",
"has_exemption": false,
"start_date": "2025-04-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953674",
"publication_url": "https://clinicaltrials.gov/study/NCT06953674",
"title": "Saline vs. Balanced Crystalloid in Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852469",
"publication_url": "https://clinicaltrials.gov/study/NCT06852469",
"title": "Individualized Computational Assessment of the Effects of GABA Receptor Modulation in Posttraumatic Stress Disorder",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940609",
"publication_url": "https://clinicaltrials.gov/study/NCT06940609",
"title": "Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation (MANIFEST)",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of New Mexico",
"sponsor_slug": "university-of-new-mexico",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943755",
"publication_url": "https://clinicaltrials.gov/study/NCT06943755",
"title": "A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06960759",
"publication_url": "https://clinicaltrials.gov/study/NCT06960759",
"title": "Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Montana",
"sponsor_slug": "university-of-montana",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217860",
"publication_url": "https://clinicaltrials.gov/study/NCT07217860",
"title": "A Multicenter, Long-term, Open-Label, Safety, Tolerability, and Efficacy Study of Azetukalner in Bipolar I or II Depression",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xenon Pharmaceuticals Inc.",
"sponsor_slug": "xenon-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174310",
"publication_url": "https://clinicaltrials.gov/study/NCT07174310",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07211958",
"publication_url": "https://clinicaltrials.gov/study/NCT07211958",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Newly Diagnosed AML With an NPM1 Mutation",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Syndax Pharmaceuticals",
"sponsor_slug": "syndax-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116395",
"publication_url": "https://clinicaltrials.gov/study/NCT07116395",
"title": "Outcomes of Tranexamic Acid With Anticoagulants in Orthopaedic Trauma Procedures: A Prospective Study",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arbi Nazarian, MD",
"sponsor_slug": "arbi-nazarian-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811545",
"publication_url": "https://clinicaltrials.gov/study/NCT06811545",
"title": "Exploring the Effects of Multi-Joint Neuromuscular Electrical Stimulation on Training Gait of Children With Cerebral Palsy",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325513",
"publication_url": "https://clinicaltrials.gov/study/NCT07325513",
"title": "Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Veterans Medical Research Foundation",
"sponsor_slug": "veterans-medical-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287995",
"publication_url": "https://clinicaltrials.gov/study/NCT07287995",
"title": "A Phase 1b/2 Study of ASP2998 as Monotherapy and in Combination With Standard Therapies in Participants With Locally Advanced Unresectable or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2026-02-05",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339111",
"publication_url": "https://clinicaltrials.gov/study/NCT07339111",
"title": "Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis",
"has_exemption": false,
"start_date": "2026-02-15",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medipost, Inc.",
"sponsor_slug": "medipost-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907173",
"publication_url": "https://clinicaltrials.gov/study/NCT06907173",
"title": "Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06224673",
"publication_url": "https://clinicaltrials.gov/study/NCT06224673",
"title": "Phase II Open-label Study of ARX788 (Anti-HER2 Antibody Drug Conjugate (ADC)) for Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Laura Huppert, MD, BA",
"sponsor_slug": "laura-huppert-md-ba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06882772",
"publication_url": "https://clinicaltrials.gov/study/NCT06882772",
"title": "Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids, A Phase IIa Clinical Trial",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109817",
"publication_url": "https://clinicaltrials.gov/study/NCT07109817",
"title": "Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer (DETOXp)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219238",
"publication_url": "https://clinicaltrials.gov/study/NCT07219238",
"title": "A Phase 2/3, Multicenter, Open-Label, Non-Randomized Study to Evaluate Diagnostic Performance of GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) for Detection of Peritoneal Carcinomatosis (PC) in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GE Healthcare",
"sponsor_slug": "ge-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365332",
"publication_url": "https://clinicaltrials.gov/study/NCT07365332",
"title": "An Adaptive, 2-Part, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of IKT-001 in Pulmonary Arterial Hypertension (PAH)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inhibikase Therapeutics",
"sponsor_slug": "inhibikase-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284602",
"publication_url": "https://clinicaltrials.gov/study/NCT07284602",
"title": "A Randomized, Double-Blind, Head-to-Head Phase 3 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone at 52 Weeks in Adults With Idiopathic Pulmonary Fibrosis (SURPASS-IPF)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PureTech",
"sponsor_slug": "puretech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441889",
"publication_url": "https://clinicaltrials.gov/study/NCT07441889",
"title": "Phase I/II Study of Anti-CD3 x Anti-HER2 Bispecific Antibody (HER2Bi) Armed Fresh Peripheral Blood Mononuclear Cells (HER2 FPBMC) in Metastatic Castrate Resistant Prostate Cancer (mCRPC) and Metastatic Breast Cancer (MBC)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258290",
"publication_url": "https://clinicaltrials.gov/study/NCT07258290",
"title": "Safety and Clinical Performance of the Drug Eluting Resorbable Coronary Magnesium Scaffold System (Freesolve) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Teleflex",
"sponsor_slug": "teleflex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290439",
"publication_url": "https://clinicaltrials.gov/study/NCT07290439",
"title": "Improving Maternal and Child Health Through Point-of-care STI Testing (MATCH-POINT)",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07306364",
"publication_url": "https://clinicaltrials.gov/study/NCT07306364",
"title": "Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07452224",
"publication_url": "https://clinicaltrials.gov/study/NCT07452224",
"title": "An Open-Label Phase II Study of ILKN421H in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "iLeukon Therapeutics, Inc.",
"sponsor_slug": "ileukon-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07471139",
"publication_url": "https://clinicaltrials.gov/study/NCT07471139",
"title": "The SWITCH Trial: A Randomized Controlled Study of Apixaban Versus Vitamin K Antagonists in Patients With HeartMate 3 Left Ventricular Assist Devices",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07298447",
"publication_url": "https://clinicaltrials.gov/study/NCT07298447",
"title": "An Open-Label Study of Donidalorsen in Pediatric Patients Age 2 to Less Than 12 Years Old With Hereditary Angioedema",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05976802",
"publication_url": "https://clinicaltrials.gov/study/NCT05976802",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch Health Americas, Inc.",
"sponsor_slug": "bausch-health-americas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236542",
"publication_url": "https://clinicaltrials.gov/study/NCT06236542",
"title": "NextGen Tracheostomy Toolkit: Integrating Augmented and Virtual Reality With Robotics to Improve Tracheostomy Care",
"has_exemption": false,
"start_date": "2027-10-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04071457",
"publication_url": "https://clinicaltrials.gov/study/NCT04071457",
"title": "S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04558736",
"publication_url": "https://clinicaltrials.gov/study/NCT04558736",
"title": "Haploidentical Donor Hematopoietic Cell Transplantation for Patients With Severe Aplastic Anemia",
"has_exemption": false,
"start_date": "2021-01-21",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561425",
"publication_url": "https://clinicaltrials.gov/study/NCT06561425",
"title": "A Phase I/II, Multicenter Study Evaluating the Feasibility, Safety, and Efficacy of Point-of-care Manufactured GLPG5101 (19CP02) in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-03-09",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Galapagos NV",
"sponsor_slug": "galapagos-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082063",
"publication_url": "https://clinicaltrials.gov/study/NCT06082063",
"title": "Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Steno Diabetes Center Copenhagen",
"sponsor_slug": "steno-diabetes-center-copenhagen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364423",
"publication_url": "https://clinicaltrials.gov/study/NCT06364423",
"title": "Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for B-cell Leukemias",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328114",
"publication_url": "https://clinicaltrials.gov/study/NCT06328114",
"title": "Functional Magnetic Resonance Imaging (fMRI)-Guided Individualized Transcranial Magnetic Stimulation (TMS) for Cervical Dystonia",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657976",
"publication_url": "https://clinicaltrials.gov/study/NCT06657976",
"title": "Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD Trial",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06650579",
"publication_url": "https://clinicaltrials.gov/study/NCT06650579",
"title": "Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02916810",
"publication_url": "https://clinicaltrials.gov/study/NCT02916810",
"title": "Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment",
"has_exemption": false,
"start_date": "2025-02-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06427798",
"publication_url": "https://clinicaltrials.gov/study/NCT06427798",
"title": "Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Paragangliomas Previously Treated With Systemic Radioligand Therapy",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06837857",
"publication_url": "https://clinicaltrials.gov/study/NCT06837857",
"title": "Imaging, Cognition, and Opioids in Older Adults With Chronic Pain (I-COAP) Trial",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06826859",
"publication_url": "https://clinicaltrials.gov/study/NCT06826859",
"title": "Dose Based Aspirin Pharmacokinetics and Pharmacodynamics in Pregnancy and Association With Pregnancy Outcomes",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013565",
"publication_url": "https://clinicaltrials.gov/study/NCT07013565",
"title": "NYMC623: A Comprehensive Risk-adapted Chemommunotherapy Protocol of Emerging Immunotherapies for Relapsed/Refractory Alk+ Anaplastic Large Cell Lymphoma (ACCELERATE)",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811038",
"publication_url": "https://clinicaltrials.gov/study/NCT06811038",
"title": "Providing Nicotine Replacement Therapy to Enhance the Efficacy of a Smoking Cessation Smartphone App for Hispanic Adults",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05453851",
"publication_url": "https://clinicaltrials.gov/study/NCT05453851",
"title": "Total Pancreatectomy With Islet Cell Autotransplantation in Patients With Benign Pancreatic Neoplasms: A Pilot Study",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06717347",
"publication_url": "https://clinicaltrials.gov/study/NCT06717347",
"title": "A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2029-07-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221474",
"publication_url": "https://clinicaltrials.gov/study/NCT07221474",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-07-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221253",
"publication_url": "https://clinicaltrials.gov/study/NCT07221253",
"title": "Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer (ARTEMIDE-Biliary02)",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2029-07-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284745",
"publication_url": "https://clinicaltrials.gov/study/NCT07284745",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2029-07-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06792825",
"publication_url": "https://clinicaltrials.gov/study/NCT06792825",
"title": "HM2023-43: A Phase 2 Trial of Tafasitamab in Combination With Lenalidomide+Rituximab in Treatment-naive Follicular Lymphoma and Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07446855",
"publication_url": "https://clinicaltrials.gov/study/NCT07446855",
"title": "A Modular Open-label, Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Ascending Doses of AZD4956 as Monotherapy, and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Repair Defective Solid Tumours",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2029-07-10",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06254482",
"publication_url": "https://clinicaltrials.gov/study/NCT06254482",
"title": "A Phase 2b, Double-Blind, Randomized Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2023-08-25",
"completion_date": "2029-07-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665256",
"publication_url": "https://clinicaltrials.gov/study/NCT06665256",
"title": "A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Refractory Idiopathic Inflammatory Myopathies (IIM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-07-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846281",
"publication_url": "https://clinicaltrials.gov/study/NCT06846281",
"title": "A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With Remibrutinib",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07090863",
"publication_url": "https://clinicaltrials.gov/study/NCT07090863",
"title": "Additively (AM) Versus Subtractively (SM) Manufactured Implant Supported Fixed Dental Prostheses (iFDPs)",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2029-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Harvard Medical School (HMS and HSDM)",
"sponsor_slug": "harvard-medical-school-hms-and-hsdm",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06528496",
"publication_url": "https://clinicaltrials.gov/study/NCT06528496",
"title": "N10: Reduced Therapy for High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2024-07-22",
"completion_date": "2029-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07099391",
"publication_url": "https://clinicaltrials.gov/study/NCT07099391",
"title": "ALTITUDE - ALTernating Induction Therapies to Achieve Undetectable Disease Endpoints: A Phase 1/2 Alternating Dara-RVd/Teclistamab-RVd in Transplant Eligible Standard-risk Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-07-24",
"completion_date": "2029-07-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06287775",
"publication_url": "https://clinicaltrials.gov/study/NCT06287775",
"title": "A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined With Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2029-07-25",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07419295",
"publication_url": "https://clinicaltrials.gov/study/NCT07419295",
"title": "A Phase 3, Randomized, Open-label Study of Sacituzumab Tirumotecan (MK-2870) Versus Investigator's Choice of Non-platinum Chemotherapy in Participants With Pretreated Locally Advanced/Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2029-07-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07444450",
"publication_url": "https://clinicaltrials.gov/study/NCT07444450",
"title": "A Phase 3, Randomized, Double-Blinded Study to Evaluate the Safety and Efficacy of Salanersen (BIIB115) After Onasemnogene Abeparvovec Treatment in Infants With Genetically Diagnosed Spinal Muscular Atrophy",
"has_exemption": false,
"start_date": "2026-09-04",
"completion_date": "2029-07-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157892",
"publication_url": "https://clinicaltrials.gov/study/NCT06157892",
"title": "A Phase 1b/2 Open-Label Study of Disitamab Vedotin in Combination With Other Anticancer Therapies in Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2029-07-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Seagen, a wholly owned subsidiary of Pfizer",
"sponsor_slug": "seagen-a-wholly-owned-subsidiary-of-pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097364",
"publication_url": "https://clinicaltrials.gov/study/NCT06097364",
"title": "A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20x Anti-CD3 Bispecific Antibody, Combined With Chemotherapy Versus Rituximab Combined With Chemotherapy in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-2)",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2029-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948318",
"publication_url": "https://clinicaltrials.gov/study/NCT06948318",
"title": "A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults With Chronic Primary Immune Thrombocytopenia",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2029-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844449",
"publication_url": "https://clinicaltrials.gov/study/NCT05844449",
"title": "A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Year of Age and Older",
"has_exemption": false,
"start_date": "2023-08-11",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06981195",
"publication_url": "https://clinicaltrials.gov/study/NCT06981195",
"title": "Neurofunctional Phenotyping to Investigate the Role of the Orexin System at the Intersection of Opioid Use Disorder and Insomnia Among Women and Men Receiving Buprenorphine",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07464912",
"publication_url": "https://clinicaltrials.gov/study/NCT07464912",
"title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing Tide Pharmaceutical Co., Ltd",
"sponsor_slug": "beijing-tide-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02307058",
"publication_url": "https://clinicaltrials.gov/study/NCT02307058",
"title": "A Phase II Randomized Trial of MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy - The Miami BLaStM Trial",
"has_exemption": false,
"start_date": "2015-02-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02081326",
"publication_url": "https://clinicaltrials.gov/study/NCT02081326",
"title": "Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02756962",
"publication_url": "https://clinicaltrials.gov/study/NCT02756962",
"title": "Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance",
"has_exemption": false,
"start_date": "2016-07-06",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02960022",
"publication_url": "https://clinicaltrials.gov/study/NCT02960022",
"title": "A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study",
"has_exemption": false,
"start_date": "2016-12-22",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04349436",
"publication_url": "https://clinicaltrials.gov/study/NCT04349436",
"title": "An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies (ARTACUS)",
"has_exemption": false,
"start_date": "2020-05-15",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Replimune Inc.",
"sponsor_slug": "replimune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684862",
"publication_url": "https://clinicaltrials.gov/study/NCT04684862",
"title": "Combined Infusion System to Deliver Chemotherapy Regionally to the Liver",
"has_exemption": false,
"start_date": "2021-02-08",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ronald DeMatteo, M.D.",
"sponsor_slug": "ronald-dematteo-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05203172",
"publication_url": "https://clinicaltrials.gov/study/NCT05203172",
"title": "ENCORAFENIB/BINIMETINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM ENCORAFENIB/BINIMETINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05481879",
"publication_url": "https://clinicaltrials.gov/study/NCT05481879",
"title": "A Randomized, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1",
"has_exemption": false,
"start_date": "2022-09-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dyne Therapeutics",
"sponsor_slug": "dyne-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05836987",
"publication_url": "https://clinicaltrials.gov/study/NCT05836987",
"title": "REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation",
"has_exemption": false,
"start_date": "2023-07-13",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05862272",
"publication_url": "https://clinicaltrials.gov/study/NCT05862272",
"title": "A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids or Moderate to Severe Pain Associated With Endometriosis",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma Switzerland GmbH",
"sponsor_slug": "sumitomo-pharma-switzerland-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06040255",
"publication_url": "https://clinicaltrials.gov/study/NCT06040255",
"title": "Focal Cerebral Arteriopathy Steroid Trial",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04858009",
"publication_url": "https://clinicaltrials.gov/study/NCT04858009",
"title": "A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328777",
"publication_url": "https://clinicaltrials.gov/study/NCT06328777",
"title": "A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis",
"has_exemption": false,
"start_date": "2024-07-02",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06536413",
"publication_url": "https://clinicaltrials.gov/study/NCT06536413",
"title": "Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib",
"has_exemption": false,
"start_date": "2024-07-29",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06171685",
"publication_url": "https://clinicaltrials.gov/study/NCT06171685",
"title": "A Phase II Randomized Adaptive Platform Trial Evaluating Novel Therapies in Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-11-17",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Multiple Myeloma Research Consortium",
"sponsor_slug": "multiple-myeloma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734351",
"publication_url": "https://clinicaltrials.gov/study/NCT06734351",
"title": "A Multicenter, Evaluator and Subject-blinded, Randomized, Comparator-controlled, Parallel-design Study to Evaluate the Safety and Effectiveness of NOA VOLUME Compared to JUVÉDERM® VOLUMA® XC for Improvement of Mid-face Volume",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846463",
"publication_url": "https://clinicaltrials.gov/study/NCT06846463",
"title": "Phase 2 Trial Utilizing Zanubrutinib in Patients With Diffuse Large B-cell Lymphoma and MYD88 L265P Mutations, CD79B Mutations, NOTCH1 Truncation or Who Are CD5+ by IHC.",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055581",
"publication_url": "https://clinicaltrials.gov/study/NCT07055581",
"title": "A Phase II Study of Durvalumab Combined With EP Prior to Chemoradiotherapy and Followed by Durvalumab as Consolidation for Patients With Limited-stage Small-cell Lung Cancer (CONCUR Study)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Qian Chu",
"sponsor_slug": "qian-chu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665074",
"publication_url": "https://clinicaltrials.gov/study/NCT06665074",
"title": "Inflammatory Challenge in Human Aggression.",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026279",
"publication_url": "https://clinicaltrials.gov/study/NCT07026279",
"title": "A Phase 1b/2a, Multicenter, Open Label Study of the Safety, Efficacy and Pharmacokinetics of Narmafotinib in Combination With Modified FOLFIRINOX in Pancreatic Cancer Patients",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amplia Therapeutics Limited",
"sponsor_slug": "amplia-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06274112",
"publication_url": "https://clinicaltrials.gov/study/NCT06274112",
"title": "Personalized Neuromodulation Targeting Dysregulated Motivational Responses Underlying Social Avoidance Behavior",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Auburn University",
"sponsor_slug": "auburn-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201207",
"publication_url": "https://clinicaltrials.gov/study/NCT07201207",
"title": "Single-center, Randomized, Controlled, Double Blinded, 24-month Trial to Compare Robotic-assisted (MAKO) and Manual Total Knee Arthroplasty for Primary Osteoarthritis With 10 Year Follow-up for Complications",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Satakunta Central Hospital",
"sponsor_slug": "satakunta-central-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06325202",
"publication_url": "https://clinicaltrials.gov/study/NCT06325202",
"title": "Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247084",
"publication_url": "https://clinicaltrials.gov/study/NCT07247084",
"title": "A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07173803",
"publication_url": "https://clinicaltrials.gov/study/NCT07173803",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217665",
"publication_url": "https://clinicaltrials.gov/study/NCT07217665",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07264283",
"publication_url": "https://clinicaltrials.gov/study/NCT07264283",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06994442",
"publication_url": "https://clinicaltrials.gov/study/NCT06994442",
"title": "Optimizing Pain Treatment in Children On Mechanical Ventilation",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227818",
"publication_url": "https://clinicaltrials.gov/study/NCT07227818",
"title": "A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157033",
"publication_url": "https://clinicaltrials.gov/study/NCT07157033",
"title": "A Phase 1/2a, Open Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of XER-001 (Amifostibe for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment of Locally-Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xerient Pharma",
"sponsor_slug": "xerient-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287449",
"publication_url": "https://clinicaltrials.gov/study/NCT07287449",
"title": "A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dymicron",
"sponsor_slug": "dymicron",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07323524",
"publication_url": "https://clinicaltrials.gov/study/NCT07323524",
"title": "Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221214",
"publication_url": "https://clinicaltrials.gov/study/NCT07221214",
"title": "GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV - GL1DER HIV RCT",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07277309",
"publication_url": "https://clinicaltrials.gov/study/NCT07277309",
"title": "Promoting Recovery After Brain Injury Using Focused Ultrasound",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06996652",
"publication_url": "https://clinicaltrials.gov/study/NCT06996652",
"title": "An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285655",
"publication_url": "https://clinicaltrials.gov/study/NCT07285655",
"title": "A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Liquidia Technologies, Inc.",
"sponsor_slug": "liquidia-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02129751",
"publication_url": "https://clinicaltrials.gov/study/NCT02129751",
"title": "A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch Health Americas, Inc.",
"sponsor_slug": "bausch-health-americas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07391774",
"publication_url": "https://clinicaltrials.gov/study/NCT07391774",
"title": "A Phase III Trial of Rx Therapy Guided by Genomic Risk Assessment For High Anatomic Stage ER-pos/HER2-neg Breast Cancer With RS</=25 (RxFINE-Low)",
"has_exemption": false,
"start_date": "2026-07-07",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449975",
"publication_url": "https://clinicaltrials.gov/study/NCT07449975",
"title": "A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Umbilical CORD-Based Skin Substitutes and Standard of Care Versus Standard of Care Alone in the Treatment of Hard-to-Heal Diabetic Foot Ulcers",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "StimLabs",
"sponsor_slug": "stimlabs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449988",
"publication_url": "https://clinicaltrials.gov/study/NCT07449988",
"title": "A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Umbilical CORD-Based Skin Substitutes and Standard of Care Versus Standard of Care Alone in the Treatment of Hard-to-Heal Venous Leg Ulcers",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "StimLabs",
"sponsor_slug": "stimlabs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04539236",
"publication_url": "https://clinicaltrials.gov/study/NCT04539236",
"title": "A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mikkael Sekeres MD",
"sponsor_slug": "mikkael-sekeres-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05377177",
"publication_url": "https://clinicaltrials.gov/study/NCT05377177",
"title": "Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression (COMBAT-SI)",
"has_exemption": false,
"start_date": "2022-09-02",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05985161",
"publication_url": "https://clinicaltrials.gov/study/NCT05985161",
"title": "A Multi-Center Phase II Study of Selinexor in Treating Recurrent or Refractory Wilms Tumor and Other Pediatric Solid Tumors",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05659381",
"publication_url": "https://clinicaltrials.gov/study/NCT05659381",
"title": "GOG-3068: A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Cisplatin Versus no HIPEC at the Time of Optimal Interval Cytoreductive Surgery Followed by Niraparib Maintenance in Patients With Homologous Recombinant Deficient (HRD +) Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (Heated Ovarian Treatment Trial)",
"has_exemption": false,
"start_date": "2024-03-08",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "GOG Foundation",
"sponsor_slug": "gog-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032389",
"publication_url": "https://clinicaltrials.gov/study/NCT07032389",
"title": "Polypill Strategy for the Treatment of Patients After Acute Coronary Syndromes - A Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819020",
"publication_url": "https://clinicaltrials.gov/study/NCT06819020",
"title": "Adaptive Deep Brain Stimulation to Improve Freezing of Gait in Parkinson's Disease Using Percept RC",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Doris Wang, MD, PhD",
"sponsor_slug": "doris-wang-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05450705",
"publication_url": "https://clinicaltrials.gov/study/NCT05450705",
"title": "A Phase 3 Open-Label Immunogenicity and Safety Study of 2-Dose Regimens of a 9vHPV Vaccine (V503) in Chinese Girls 9 Through 14 Years of Age With a Comparison to 3-Dose Regimen of V503 in Chinese Women 20 Through 26 Years of Age",
"has_exemption": false,
"start_date": "2022-07-22",
"completion_date": "2029-08-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285460",
"publication_url": "https://clinicaltrials.gov/study/NCT07285460",
"title": "An Open-label, Parallel, Phase 3, Two-arm Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B With or Without Inhibitory Antibodies to Factors VIII or IX",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2029-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285798",
"publication_url": "https://clinicaltrials.gov/study/NCT07285798",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2029-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04849871",
"publication_url": "https://clinicaltrials.gov/study/NCT04849871",
"title": "Evaluation of Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma - BreaStBRT",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2029-08-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03645928",
"publication_url": "https://clinicaltrials.gov/study/NCT03645928",
"title": "A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN 144/LN-145/LN-145-S1) in Patients With Solid Tumors",
"has_exemption": false,
"start_date": "2019-05-07",
"completion_date": "2029-08-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07065630",
"publication_url": "https://clinicaltrials.gov/study/NCT07065630",
"title": "A Phase II Study of Volrustomig, Paclitaxel, and Carboplatin Followed by Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2029-08-13",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07184944",
"publication_url": "https://clinicaltrials.gov/study/NCT07184944",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2029-08-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06992427",
"publication_url": "https://clinicaltrials.gov/study/NCT06992427",
"title": "High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2029-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07081646",
"publication_url": "https://clinicaltrials.gov/study/NCT07081646",
"title": "A Phase 1b/2 Study of AZD0120 (Also Known as GC012F), a Chimeric Antigen Receptor T Cell Therapy Targeting CD19 and B Cell Maturation Antigen in Participants With Relapsed or Refractory AL Amyloidosis.",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07412470",
"publication_url": "https://clinicaltrials.gov/study/NCT07412470",
"title": "A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2026-03-02",
"completion_date": "2029-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07431281",
"publication_url": "https://clinicaltrials.gov/study/NCT07431281",
"title": "A Phase III, Multicentre, Randomised Controlled Study of Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in First-Line Claudin18.2-Positive, HER2-Negative, Advanced/Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (CLARITY-Gastric 02)",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2029-08-16",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959095",
"publication_url": "https://clinicaltrials.gov/study/NCT06959095",
"title": "A Randomized, Double-Blind, Placebo- Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab In Adult Participants With COPD With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2029-08-20",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961214",
"publication_url": "https://clinicaltrials.gov/study/NCT06961214",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab in Adult Participants With COPD With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2029-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441642",
"publication_url": "https://clinicaltrials.gov/study/NCT07441642",
"title": "A Randomized, Double Masked, Placebo-controlled, Multicenter, Dose-range Finding Study to Assess the Efficacy and Safety of FWY003 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2029-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635148",
"publication_url": "https://clinicaltrials.gov/study/NCT06635148",
"title": "Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies",
"has_exemption": false,
"start_date": "2024-09-19",
"completion_date": "2029-08-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03899155",
"publication_url": "https://clinicaltrials.gov/study/NCT03899155",
"title": "Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies",
"has_exemption": false,
"start_date": "2020-05-05",
"completion_date": "2029-08-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07454382",
"publication_url": "https://clinicaltrials.gov/study/NCT07454382",
"title": "Phase 2 Trial of Elranatamab With Cyclophosphamide in Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2029-08-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04365374",
"publication_url": "https://clinicaltrials.gov/study/NCT04365374",
"title": "A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (STaRT) With Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors.",
"has_exemption": false,
"start_date": "2021-04-06",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GT Medical Technologies, Inc.",
"sponsor_slug": "gt-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06088290",
"publication_url": "https://clinicaltrials.gov/study/NCT06088290",
"title": "Randomized, Controlled, Open-label, Phase III Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Patients With Metastatic Leiomyosarcoma",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PharmaMar",
"sponsor_slug": "pharmamar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07242105",
"publication_url": "https://clinicaltrials.gov/study/NCT07242105",
"title": "Optimized Methods for Measuring Brain Excitability in Depression",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06837480",
"publication_url": "https://clinicaltrials.gov/study/NCT06837480",
"title": "Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors With Chronic Lymphedema",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07104331",
"publication_url": "https://clinicaltrials.gov/study/NCT07104331",
"title": "SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma",
"has_exemption": false,
"start_date": "2026-02-24",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Alliance for Research through Collaboration",
"sponsor_slug": "sarcoma-alliance-for-research-through-collaboration",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03228667",
"publication_url": "https://clinicaltrials.gov/study/NCT03228667",
"title": "QUILT-3.055: A Phase IIb, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2018-12-11",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03737214",
"publication_url": "https://clinicaltrials.gov/study/NCT03737214",
"title": "A Multi-center, Open-label, Uncontrolled, Single-arm, Extension Study to Determine the Long-term Safety and Tolerability of Oral Lucerastat in Adult Subjects With Fabry Disease",
"has_exemption": false,
"start_date": "2018-12-18",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Idorsia Pharmaceuticals Ltd.",
"sponsor_slug": "idorsia-pharmaceuticals-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05071300",
"publication_url": "https://clinicaltrials.gov/study/NCT05071300",
"title": "An Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy",
"has_exemption": false,
"start_date": "2022-01-04",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307055",
"publication_url": "https://clinicaltrials.gov/study/NCT05307055",
"title": "Theta Burst Subthalamic Nucleus Deep Brain Stimulation for Cognitive and Motor Improvements in Parkinson's Disease",
"has_exemption": false,
"start_date": "2022-01-11",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05461170",
"publication_url": "https://clinicaltrials.gov/study/NCT05461170",
"title": "A Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of VIR-2218 and VIR-3434 in Participants With Chronic Hepatitis D Virus Infection (SOLSTICE)",
"has_exemption": false,
"start_date": "2022-09-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vir Biotechnology, Inc.",
"sponsor_slug": "vir-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05604131",
"publication_url": "https://clinicaltrials.gov/study/NCT05604131",
"title": "Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients",
"has_exemption": false,
"start_date": "2022-11-08",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rohan Dharmakumar",
"sponsor_slug": "rohan-dharmakumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667493",
"publication_url": "https://clinicaltrials.gov/study/NCT05667493",
"title": "An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (ION-682884) in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05496998",
"publication_url": "https://clinicaltrials.gov/study/NCT05496998",
"title": "Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiovascular",
"sponsor_slug": "medtronic-cardiovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05777993",
"publication_url": "https://clinicaltrials.gov/study/NCT05777993",
"title": "A Rollover Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study",
"has_exemption": false,
"start_date": "2023-07-06",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agios Pharmaceuticals, Inc.",
"sponsor_slug": "agios-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05838287",
"publication_url": "https://clinicaltrials.gov/study/NCT05838287",
"title": "Pioglitazone, Lipotoxicity, and Heart Failure With Preserved Ejection Fraction (HFpEF)",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06066580",
"publication_url": "https://clinicaltrials.gov/study/NCT06066580",
"title": "An Open-Label Extension Study to Assess the Long-term Effect of EDG-5506 on Safety, Biomarkers, and Functional Measures in Adults and Adolescents With Becker Muscular Dystrophy",
"has_exemption": false,
"start_date": "2023-11-02",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edgewise Therapeutics, Inc.",
"sponsor_slug": "edgewise-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05832229",
"publication_url": "https://clinicaltrials.gov/study/NCT05832229",
"title": "Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364280",
"publication_url": "https://clinicaltrials.gov/study/NCT06364280",
"title": "Pediatric Prehospital Airway Resuscitation Trial",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06219174",
"publication_url": "https://clinicaltrials.gov/study/NCT06219174",
"title": "Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05843253",
"publication_url": "https://clinicaltrials.gov/study/NCT05843253",
"title": "Phase 2 Study of Ribociclib-Containing Post-Radiotherapy Combinations in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma: Ribociclib and Everolimus for HGG/DIPG Which Harbor Alterations of the Cell Cycle and/or PI3K/mTOR Pathways AND Ribociclib and Temozolomide for DHG, H3G34-mutant",
"has_exemption": false,
"start_date": "2024-08-22",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553872",
"publication_url": "https://clinicaltrials.gov/study/NCT06553872",
"title": "A Phase 2, Open-Label, Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-08-23",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492616",
"publication_url": "https://clinicaltrials.gov/study/NCT06492616",
"title": "Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase 3 Study",
"has_exemption": false,
"start_date": "2024-09-27",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050355",
"publication_url": "https://clinicaltrials.gov/study/NCT07050355",
"title": "Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking (RESTORATION)",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06517212",
"publication_url": "https://clinicaltrials.gov/study/NCT06517212",
"title": "Adjuvant Tirzepatide Plus Standard of Care Endocrine Therapy in Patients With Obesity or Overweight Who Have Hormone Receptor-positive, HER2-negative, Node-positive Early Breast Cancer, With Molecular Residual Disease (MRD), as Determined by Circulating Tumor DNA (ctDNA)",
"has_exemption": false,
"start_date": "2024-11-26",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105164",
"publication_url": "https://clinicaltrials.gov/study/NCT06105164",
"title": "Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans",
"has_exemption": false,
"start_date": "2024-12-05",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06517888",
"publication_url": "https://clinicaltrials.gov/study/NCT06517888",
"title": "A Phase 1/2 Trial of AAVAnc80-antiVEGF Gene Therapy in Individuals With Unilateral Vestibular Schwannoma",
"has_exemption": false,
"start_date": "2025-01-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Akouos, Inc.",
"sponsor_slug": "akouos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780137",
"publication_url": "https://clinicaltrials.gov/study/NCT06780137",
"title": "A Phase 1b/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788756",
"publication_url": "https://clinicaltrials.gov/study/NCT06788756",
"title": "A Pivotal Phase 2/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L Annamycin for Injection in Combination With Cytarabine Injection Versus Placebo in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleculin Biotech, Inc.",
"sponsor_slug": "moleculin-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956300",
"publication_url": "https://clinicaltrials.gov/study/NCT06956300",
"title": "Grit Against Cognitive Decline in Aging and Preclinical Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811233",
"publication_url": "https://clinicaltrials.gov/study/NCT06811233",
"title": "Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study",
"has_exemption": false,
"start_date": "2025-05-08",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902558",
"publication_url": "https://clinicaltrials.gov/study/NCT06902558",
"title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044635",
"publication_url": "https://clinicaltrials.gov/study/NCT07044635",
"title": "Radiation Therapy in Reduced Dose and Hypofractionated Schedule After Trans-Oral Robotic Surgery in Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06993675",
"publication_url": "https://clinicaltrials.gov/study/NCT06993675",
"title": "Improving MRD Negativity Rates in Newly Diagnosed Multiple Myeloma Patients: a Response-adaptive Approach of Consolidation With One or Two Bispecific T-cell Engagers Against GPRC5D or BCMA",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Noffar Bar",
"sponsor_slug": "noffar-bar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06725550",
"publication_url": "https://clinicaltrials.gov/study/NCT06725550",
"title": "Integrative Medicine in Pain Management in Sickle Cell Disease: Assessing the Clinical Efficacy and Neurobiological Impact With Acupuncture, 2.0",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866964",
"publication_url": "https://clinicaltrials.gov/study/NCT06866964",
"title": "A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06703216",
"publication_url": "https://clinicaltrials.gov/study/NCT06703216",
"title": "Pilot Study of Pre-emptive Anakinra for the Prevention of Severe Cytokine Release Syndrome in Children and Young Adults With B-Acute Lymphoblastic Leukemia Receiving Chimeric Antigen Receptor (CAR) T Cells",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ann & Robert H Lurie Children's Hospital of Chicago",
"sponsor_slug": "ann-robert-h-lurie-childrens-hospital-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06629259",
"publication_url": "https://clinicaltrials.gov/study/NCT06629259",
"title": "Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07086131",
"publication_url": "https://clinicaltrials.gov/study/NCT07086131",
"title": "Impact Of Adding Inspiratory Muscle Training To Cardiac Rehabilitation On Exercise Responses In Heart Failure",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212114",
"publication_url": "https://clinicaltrials.gov/study/NCT07212114",
"title": "A Randomized, Double-blind, Active Controlled, Single-center Study to Evaluate the Efficacy of EXPAREL vs. Bupivacaine HCl Administered as Combined Sciatic (in the Popliteal Fossa) and Saphenous (in the Adductor Canal) Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Total Ankle Arthroplasty",
"has_exemption": false,
"start_date": "2025-11-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06955169",
"publication_url": "https://clinicaltrials.gov/study/NCT06955169",
"title": "MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RTOG Foundation, Inc.",
"sponsor_slug": "rtog-foundation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223541",
"publication_url": "https://clinicaltrials.gov/study/NCT07223541",
"title": "A Randomized Phase II Trial of Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Oligo-Metastatic Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625073",
"publication_url": "https://clinicaltrials.gov/study/NCT06625073",
"title": "Randomized Trial of Sodium-glucose Cotransporter 2 Inhibition in Heart Transplant Recipients",
"has_exemption": false,
"start_date": "2026-01-20",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07279558",
"publication_url": "https://clinicaltrials.gov/study/NCT07279558",
"title": "Effects of Full-spectrum Cannabidiol on Alcohol Consumption and Alcohol Use Disorder Phenotypes: Implications for Precision Medicine",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201129",
"publication_url": "https://clinicaltrials.gov/study/NCT07201129",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of Cenerimod in Adult Patients With Systemic Lupus Erythematosus and Active Lupus Nephritis in Combination With Background Therapy",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Viatris Innovation GmbH",
"sponsor_slug": "viatris-innovation-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07409272",
"publication_url": "https://clinicaltrials.gov/study/NCT07409272",
"title": "A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ASP3082 in Combination With mFOLFIRINOX or NALIRIFOX as First-line Treatment in Participants With KRAS G12D Mutated Metastatic Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-02-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222579",
"publication_url": "https://clinicaltrials.gov/study/NCT07222579",
"title": "A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325214",
"publication_url": "https://clinicaltrials.gov/study/NCT07325214",
"title": "A Randomized Pivotal Clinical Trial Evaluating Chemotherapy Regimen Consisting of Irinotecan Hydrochloride, Oxaliplatin, Fluorouracil (5-FU) and Leucovorin With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable Pancreatic Cancer or Locally Advanced Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "IMGT Co., Ltd.",
"sponsor_slug": "imgt-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422469",
"publication_url": "https://clinicaltrials.gov/study/NCT05422469",
"title": "Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940570",
"publication_url": "https://clinicaltrials.gov/study/NCT06940570",
"title": "A Randomized Single Center Trial to Determine the Efficacy of Methadone as a First Line Agent in the Reduction and Treatment of Pain in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2028-01-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05963698",
"publication_url": "https://clinicaltrials.gov/study/NCT05963698",
"title": "The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06586021",
"publication_url": "https://clinicaltrials.gov/study/NCT06586021",
"title": "SEAL - Safety & Feasibility Evaluation of the Aortoseal™ for Seal and Fixation of Abdominal Aortic Aneurysms (AAA) Endovascular Grafts to the Aortic Wall\"",
"has_exemption": false,
"start_date": "2024-02-06",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endoron Medical",
"sponsor_slug": "endoron-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722391",
"publication_url": "https://clinicaltrials.gov/study/NCT06722391",
"title": "Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas, El Paso",
"sponsor_slug": "university-of-texas-el-paso",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525740",
"publication_url": "https://clinicaltrials.gov/study/NCT06525740",
"title": "Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06580041",
"publication_url": "https://clinicaltrials.gov/study/NCT06580041",
"title": "Precision Care for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-11-12",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483061",
"publication_url": "https://clinicaltrials.gov/study/NCT06483061",
"title": "Ferumoxytol Enhanced Hippocampal Vascular Imaging in Epilepsy",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alberta",
"sponsor_slug": "university-of-alberta",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06949423",
"publication_url": "https://clinicaltrials.gov/study/NCT06949423",
"title": "Accessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06645613",
"publication_url": "https://clinicaltrials.gov/study/NCT06645613",
"title": "Precision TMS With Integrated Visualization and Analysis of Real-time E-field and EEG Source Imaging",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855433",
"publication_url": "https://clinicaltrials.gov/study/NCT06855433",
"title": "A Randomized, Double-Blind, Multi-Site Placebo Controlled Trial of Colchicine in Calcium Pyrophosphate Deposition Disease",
"has_exemption": false,
"start_date": "2026-04-10",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187375",
"publication_url": "https://clinicaltrials.gov/study/NCT07187375",
"title": "A Phase 2, Open-Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Crinecerfont in Pediatric Subjects 0 to <2 Years of Age With Congenital Adrenal Hyperplasia",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04994717",
"publication_url": "https://clinicaltrials.gov/study/NCT04994717",
"title": "Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05827081",
"publication_url": "https://clinicaltrials.gov/study/NCT05827081",
"title": "A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER)",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875310",
"publication_url": "https://clinicaltrials.gov/study/NCT06875310",
"title": "A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282613",
"publication_url": "https://clinicaltrials.gov/study/NCT07282613",
"title": "Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-08-04",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06469944",
"publication_url": "https://clinicaltrials.gov/study/NCT06469944",
"title": "A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma): Substudy 06C",
"has_exemption": false,
"start_date": "2024-09-20",
"completion_date": "2029-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714202",
"publication_url": "https://clinicaltrials.gov/study/NCT05714202",
"title": "A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2029-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04123795",
"publication_url": "https://clinicaltrials.gov/study/NCT04123795",
"title": "Multicenter, Open Label or Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Pediatric Study Participants With Moderate to Severe Chronic Plaque Psoriasis",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2029-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04794101",
"publication_url": "https://clinicaltrials.gov/study/NCT04794101",
"title": "Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene",
"has_exemption": false,
"start_date": "2020-12-04",
"completion_date": "2029-09-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024394",
"publication_url": "https://clinicaltrials.gov/study/NCT07024394",
"title": "A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Ruvometinib Tablets (FCN-159 Tablets) in Pediatric Participants With Neurofibromatosis Type 1",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.",
"sponsor_slug": "shanghai-fosun-pharmaceutical-industrial-development-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05485961",
"publication_url": "https://clinicaltrials.gov/study/NCT05485961",
"title": "A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis",
"has_exemption": false,
"start_date": "2022-10-21",
"completion_date": "2029-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04802603",
"publication_url": "https://clinicaltrials.gov/study/NCT04802603",
"title": "Dose-Escalated Spine SbRT (DESSRT) for Localized Metastasis to the Spinal Column",
"has_exemption": false,
"start_date": "2021-03-14",
"completion_date": "2029-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02915198",
"publication_url": "https://clinicaltrials.gov/study/NCT02915198",
"title": "CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT)",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2029-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00781612",
"publication_url": "https://clinicaltrials.gov/study/NCT00781612",
"title": "An Open-Label, Multicenter Extension Study of Trastuzumab Emtansine Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd-Sponsored Trastuzumab Emtansine Study",
"has_exemption": false,
"start_date": "2008-10-16",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03770572",
"publication_url": "https://clinicaltrials.gov/study/NCT03770572",
"title": "Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9",
"has_exemption": false,
"start_date": "2018-11-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alcyone Therapeutics, Inc",
"sponsor_slug": "alcyone-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04692181",
"publication_url": "https://clinicaltrials.gov/study/NCT04692181",
"title": "Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Recipients",
"has_exemption": false,
"start_date": "2021-02-15",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Theriva Biologics, Inc.",
"sponsor_slug": "theriva-biologics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05374590",
"publication_url": "https://clinicaltrials.gov/study/NCT05374590",
"title": "A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2022-08-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05445323",
"publication_url": "https://clinicaltrials.gov/study/NCT05445323",
"title": "A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's Ataxia",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lexeo Therapeutics",
"sponsor_slug": "lexeo-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05489887",
"publication_url": "https://clinicaltrials.gov/study/NCT05489887",
"title": "A Phase II Study of Naxitamab Added to Induction Therapy for Subjects With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2022-09-14",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409989",
"publication_url": "https://clinicaltrials.gov/study/NCT05409989",
"title": "MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Microvention-Terumo, Inc.",
"sponsor_slug": "microvention-terumo-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05405361",
"publication_url": "https://clinicaltrials.gov/study/NCT05405361",
"title": "A Long-term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy",
"has_exemption": false,
"start_date": "2023-01-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05633667",
"publication_url": "https://clinicaltrials.gov/study/NCT05633667",
"title": "A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung)",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05891821",
"publication_url": "https://clinicaltrials.gov/study/NCT05891821",
"title": "Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)",
"has_exemption": false,
"start_date": "2023-09-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immune Oncology Research Institute",
"sponsor_slug": "immune-oncology-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465745",
"publication_url": "https://clinicaltrials.gov/study/NCT06465745",
"title": "AltaValve Pivotal Trial",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "4C Medical Technologies, Inc.",
"sponsor_slug": "4c-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06528314",
"publication_url": "https://clinicaltrials.gov/study/NCT06528314",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akero Therapeutics, Inc",
"sponsor_slug": "akero-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657859",
"publication_url": "https://clinicaltrials.gov/study/NCT06657859",
"title": "A Phase 2, Open-Label Extension Study to Assess the Safety and Efficacy of GLM101 Administered Intravenously to Participants With PMM2-CDG",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Glycomine, Inc.",
"sponsor_slug": "glycomine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095205",
"publication_url": "https://clinicaltrials.gov/study/NCT07095205",
"title": "Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine",
"has_exemption": false,
"start_date": "2024-10-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06557512",
"publication_url": "https://clinicaltrials.gov/study/NCT06557512",
"title": "A Pilot Trial of Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma (SRS-AIM)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526195",
"publication_url": "https://clinicaltrials.gov/study/NCT06526195",
"title": "Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06359041",
"publication_url": "https://clinicaltrials.gov/study/NCT06359041",
"title": "RESET-MG: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406452",
"publication_url": "https://clinicaltrials.gov/study/NCT06406452",
"title": "A Multi-Center Trial to Assess the Safety and Effectiveness of a Bioresorbable Tracheobronchial Splint in Pediatric Subjects With Clinically Significant Tracheobronchomalacia",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06493552",
"publication_url": "https://clinicaltrials.gov/study/NCT06493552",
"title": "A Modular, Open Label, Randomized Phase II/III Trial to Assess Efficacy of Combining sEphB4-HSA (EphrinB2 Inhibitor) With Immunotherapy Regimens in Patients With EphrinB2-High Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-15",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vasgene Therapeutics, Inc",
"sponsor_slug": "vasgene-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553885",
"publication_url": "https://clinicaltrials.gov/study/NCT06553885",
"title": "A Phase II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic Colorectal Cancer or Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943872",
"publication_url": "https://clinicaltrials.gov/study/NCT06943872",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-06-11",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07151677",
"publication_url": "https://clinicaltrials.gov/study/NCT07151677",
"title": "Pre-Frontal tDCS as a Novel Intervention to Reduce Effects of Post-Stroke Fatigue While Improving Language and Attention in Aphasia",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Syracuse University",
"sponsor_slug": "syracuse-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011771",
"publication_url": "https://clinicaltrials.gov/study/NCT07011771",
"title": "A Phase 1/2 Dose-Escalation Trial to Evaluate Safety, Tolerability, and Efficacy of a Single Dose of CAP-003 Gene Therapy Administered to Patients With Parkinson's Disease With GBA1 Gene Mutation (PD-GBA)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Capsida Biotherapeutics, Inc.",
"sponsor_slug": "capsida-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145255",
"publication_url": "https://clinicaltrials.gov/study/NCT07145255",
"title": "A Multicenter, Open-label Phase 1/2 Dose Finding, Safety, and Pharmacokinetic Study of MBRC-201, an Antibody-drug Conjugate, in Advanced Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MBrace Therapeutics",
"sponsor_slug": "mbrace-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091734",
"publication_url": "https://clinicaltrials.gov/study/NCT07091734",
"title": "Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07140679",
"publication_url": "https://clinicaltrials.gov/study/NCT07140679",
"title": "A Phase II Trial of Adjuvant Toripalimab in High Risk Localized Colon Cancer With Mismatch Repair Deficiency",
"has_exemption": false,
"start_date": "2025-09-19",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07151248",
"publication_url": "https://clinicaltrials.gov/study/NCT07151248",
"title": "ELECTRIG: Evaluating Effects of Cranial Electrical Stimulation Therapy With Responsive Imaging in Gulf War Illness Pain and Comorbid Symptoms",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07198529",
"publication_url": "https://clinicaltrials.gov/study/NCT07198529",
"title": "Optical Coherence Tomography for Stent Optimization and Its Impact on Short-Duration Dual Antiplatelet Therapy: A Single-Center, Prospective, Exploratory Study",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Korea University Guro Hospital",
"sponsor_slug": "korea-university-guro-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178145",
"publication_url": "https://clinicaltrials.gov/study/NCT07178145",
"title": "MRI of Epicardial Adipose Tissue Composition: Development of Methods and Application to Heart Failure With Preserved Ejection Fraction",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06933706",
"publication_url": "https://clinicaltrials.gov/study/NCT06933706",
"title": "Losartan to Improve Outcomes After Multi-ligament Knee Injury",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284784",
"publication_url": "https://clinicaltrials.gov/study/NCT07284784",
"title": "An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Annovis Bio Inc.",
"sponsor_slug": "annovis-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}